PDA’s Glenn Wright Named Chairman of Product Quality Research Institute Board of Directors

Share Article

Mr. Wright has 18 years of involvement with PQRI.

PDA, Inc.

Mr. Wright has participated in PQRI since 2003.

The Parenteral Drug Association, Inc. (PDA) has announced that Glenn Wright, Vice President of Scientific and Regulatory Affairs, was named the Chairman of the Product Quality Research Institute’s (PQRI) Board of Directors. Mr. Wright has participated in PQRI since 2003.

PQRI is a non-profit consortium of organizations working together to generate and share timely, relevant, and impactful information that advances global drug product quality, manufacturing, and regulation.

PDA has been a supporting member of PQRI since it was founded in the late 1990s.

Besides, PDA, two regulatory authorities and a number of nongovernmental organizations comprise PQRI. The member organizations are:


  • Health Canada
  • U.S. Food and Drug Administration


  • Consumer Healthcare Products Association
  • International Pharmaceutical Excipients Council of the Americas
  • PDA, Inc.
  • U.S. Pharmacopeial Convention

The Board of Directors is vested with the administrative management, growth, and operation of the Institute, except for those activities involving scientific decision making, which are delegated to the PQRI Steering Committee. The Board has authority over the collection and disbursement of funds and the administrative procedures required to ensure the effective operation of the Institute.

The Steering Committee has sole authority over all scientific activities conducted under the auspices of the Institute and is responsible for recommending the disbursement of funds towards those activities, to the Board of Directors.

PQRI currently supports three technical committees that guide working groups:

  • Development Technical Committee
  • Product Quality Technical Committee
  • Biopharmaceutics Technical Committee

For more information on PQRI and its work, visit its website: https://pqri.org/about-pqri/

About PDA – Connecting People, Science and Regulation®
The Parenteral Drug Association (PDA) is the leading global provider of science, technology and regulatory information and education for the pharmaceutical and biopharmaceutical community. Founded in 1946 as a nonprofit organization, PDA is committed to developing scientifically sound, practical technical information and resources to advance science and regulation through the expertise of over 10,500 members worldwide. PDA is an ANSI accredited Standards Developing Organization. Go to http://www.pda.org/footer/about-pda to learn more.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Walter Morris
PDA, Inc.
+1 (301) 656-5900 Ext: 148
Email >
Follow >
Visit website